Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology☆

Add time:09/06/2019    Source:sciencedirect.com

Compound 5 (SCH772984) was identified as a potent inhibitor of ERK1/2 with excellent selectivity against a panel of kinases (0/231 kinases tested @ 100 nM) and good cell proliferation activity, but suffered from poor PK (rat AUC PK @10 mpk = 0 μM h; F% = 0) which precluded further development. In an effort to identify novel ERK inhibitors with improved PK properties with respect to 5, a systematic exploration of sterics and composition at the 3-position of the pyrrolidine led to the discovery of a novel 3(S)-thiomethyl pyrrolidine analog 28 with vastly improved PK (rat AUC PK @10 mpk = 26 μM h; F% = 70).

We also recommend Trading Suppliers and Manufacturers of Pyrrolidine, 1-chloro- (cas 19733-68-7). Pls Click Website Link as below: cas 19733-68-7 suppliers

Prev:Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives
Next:Spiro[pyrrolidine-3,3′-oxindoles] as 5-HT7 receptor ligands)